Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co‐Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8‐Week Randomized Controlled Trial of Acamprosate
Identifieur interne : 001409 ( Main/Exploration ); précédent : 001408; suivant : 001410Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co‐Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8‐Week Randomized Controlled Trial of Acamprosate
Auteurs : James J. Prisciandaro [États-Unis] ; Stacia M. Desantis [États-Unis] ; Cody Chiuzan [États-Unis] ; Delisa G. Brown [États-Unis] ; Kathleen T. Brady [États-Unis] ; Bryan K. Tolliver [États-Unis]Source :
- Alcoholism: Clinical and Experimental Research [ 0145-6008 ] ; 2012-03.
English descriptors
- Teeft :
- Acamprosate, Acamprosate group status, Active phase, Acute mania, Alcohol, Alcohol abuse, Alcohol consumption, Alcohol craving, Alcohol dependence, Alcoholic beverages, Anxiety disorder, Asberg, Baseline, Behavioral sciences, Bipolar, Bipolar disorder, Bipolar disorder patients, Bipolar disorders, Bipolar patients, Bipolar symptoms, Categorical measures, Clin, Clinical interview, Clinical neuroscience division, Clinical trials, Comorbid, Covariates depressive symptoms, Craving, Credible interval, Credible intervals, Current drinking, Depressive, Depressive symptoms, Desantis, Disord, Disorder, Drinking behavior, Drinking days, Drinking outcomes, Drinking percentage, Drinking scale, Drinking state, Drinks percentage, Excessive alcohol, Exclusion criteria, Fleck, Forest laboratories, Future alcohol, Heavy drinking days, Heavy drinking state, Imminent risk, Latent states, Madrs, Manic symptoms, Markov, Markov model, Markov modeling, Markov models, Mcmc sampler, Measurement error, Medical university, Montgomery asberg depression rating scale, Mood outcomes, Mood symptoms, Neuropsychiatric interview, Obsessive, Ocds, Odds ratios, Other studies, Parameter estimates, Participant, Placebo, Present study, Prospective association, Proximal, Proximal impact, Psychiatry, Randomized, Salloum, Spearman correlations, Strakowski, Study design, Study psychiatrist, Study week, Subsequent alcohol, Substance abuse, Summary measures, Symptom, Systematic treatment enhancement program, Treatment group, Unobserved drinking state, Weekly visit, Weiss, Ymrs, Ymrs scores, Young mania rating scale.
Abstract
Background: Bipolar disorders and alcohol use disorders commonly co‐occur, yet little is known about the proximal impact of bipolar symptoms on alcohol use in patients with this comorbidity. The present study examined the impact of depressive symptoms and alcohol craving on proximal alcohol use in patients with co‐occurring bipolar disorder and alcohol dependence. Methods: Data were collected during an 8‐week randomized controlled trial of acamprosate for individuals with co‐occurring bipolar disorder and alcohol dependence (n = 30). Depressive symptoms and alcohol craving were assessed biweekly using the Montgomery Asberg Depression Rating Scale (MADRS) and the Obsessive Compulsive Drinking Scale (OCDS), respectively. Daily alcohol use data were available via administration of the Time‐line Follow‐back interview at baseline and at subsequent weekly study visits. Correlational analyses and hidden Markov modeling were used to examine the prospective relationships between depressive symptoms, alcohol craving, and alcohol use. Results: Depressive symptoms and alcohol craving were significantly correlated with proximal (i.e., 1 week later) alcohol use across a variety of alcohol consumption summary measures. In hidden Markov models, depressive symptoms (OR = 1.3, 95% credible interval = [1.1, 1.5]) and alcohol craving (OR = 1.6, 95% credible interval = [1.4, 1.9]) significantly predicted transitioning from a light to a heavy drinking state, or remaining in a heavy drinking state. Conclusions: The results from the present study suggest that depressive symptoms and alcohol craving increase proximal risk for alcohol use in individuals with co‐occurring bipolar and alcohol use disorders.
Url:
DOI: 10.1111/j.1530-0277.2011.01645.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001620
- to stream Istex, to step Curation: 001547
- to stream Istex, to step Checkpoint: 000470
- to stream Main, to step Merge: 001411
- to stream Main, to step Curation: 001409
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co‐Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8‐Week Randomized Controlled Trial of Acamprosate</title><author><name sortKey="Prisciandaro, James J" sort="Prisciandaro, James J" uniqKey="Prisciandaro J" first="James J." last="Prisciandaro">James J. Prisciandaro</name></author><author><name sortKey="Desantis, Stacia M" sort="Desantis, Stacia M" uniqKey="Desantis S" first="Stacia M." last="Desantis">Stacia M. Desantis</name></author><author><name sortKey="Chiuzan, Cody" sort="Chiuzan, Cody" uniqKey="Chiuzan C" first="Cody" last="Chiuzan">Cody Chiuzan</name></author><author><name sortKey="Brown, Delisa G" sort="Brown, Delisa G" uniqKey="Brown D" first="Delisa G." last="Brown">Delisa G. Brown</name></author><author><name sortKey="Brady, Kathleen T" sort="Brady, Kathleen T" uniqKey="Brady K" first="Kathleen T." last="Brady">Kathleen T. Brady</name></author><author><name sortKey="Tolliver, Bryan K" sort="Tolliver, Bryan K" uniqKey="Tolliver B" first="Bryan K." last="Tolliver">Bryan K. Tolliver</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F1060A25EBE4BDF27B7C28182B5A3697DC603BFB</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1111/j.1530-0277.2011.01645.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-N4X1G9WP-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001620</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001620</idno><idno type="wicri:Area/Istex/Curation">001547</idno><idno type="wicri:Area/Istex/Checkpoint">000470</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000470</idno><idno type="wicri:doubleKey">0145-6008:2012:Prisciandaro J:impact:of:depressive</idno><idno type="wicri:Area/Main/Merge">001411</idno><idno type="wicri:Area/Main/Curation">001409</idno><idno type="wicri:Area/Main/Exploration">001409</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co‐Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8‐Week Randomized Controlled Trial of Acamprosate</title><author><name sortKey="Prisciandaro, James J" sort="Prisciandaro, James J" uniqKey="Prisciandaro J" first="James J." last="Prisciandaro">James J. Prisciandaro</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Desantis, Stacia M" sort="Desantis, Stacia M" uniqKey="Desantis S" first="Stacia M." last="Desantis">Stacia M. Desantis</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Chiuzan, Cody" sort="Chiuzan, Cody" uniqKey="Chiuzan C" first="Cody" last="Chiuzan">Cody Chiuzan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Brown, Delisa G" sort="Brown, Delisa G" uniqKey="Brown D" first="Delisa G." last="Brown">Delisa G. Brown</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Brady, Kathleen T" sort="Brady, Kathleen T" uniqKey="Brady K" first="Kathleen T." last="Brady">Kathleen T. Brady</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Tolliver, Bryan K" sort="Tolliver, Bryan K" uniqKey="Tolliver B" first="Bryan K." last="Tolliver">Bryan K. Tolliver</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>From the Clinical Neuroscience Division (JJP, DGB, KTB, BKT), Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Division of Biostatistics and Epidemiology (SMD, CC), Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H Johnson Veterans Administration Medical Center (KTB), Charleston</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Alcoholism: Clinical and Experimental Research</title><title level="j" type="alt">ALCOHOLISM CLINICAL EXPERIMENTAL RESEARCH</title><idno type="ISSN">0145-6008</idno><idno type="eISSN">1530-0277</idno><imprint><biblScope unit="vol">36</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="490">490</biblScope><biblScope unit="page" to="496">496</biblScope><biblScope unit="page-count">7</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2012-03">2012-03</date></imprint><idno type="ISSN">0145-6008</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0145-6008</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acamprosate</term><term>Acamprosate group status</term><term>Active phase</term><term>Acute mania</term><term>Alcohol</term><term>Alcohol abuse</term><term>Alcohol consumption</term><term>Alcohol craving</term><term>Alcohol dependence</term><term>Alcoholic beverages</term><term>Anxiety disorder</term><term>Asberg</term><term>Baseline</term><term>Behavioral sciences</term><term>Bipolar</term><term>Bipolar disorder</term><term>Bipolar disorder patients</term><term>Bipolar disorders</term><term>Bipolar patients</term><term>Bipolar symptoms</term><term>Categorical measures</term><term>Clin</term><term>Clinical interview</term><term>Clinical neuroscience division</term><term>Clinical trials</term><term>Comorbid</term><term>Covariates depressive symptoms</term><term>Craving</term><term>Credible interval</term><term>Credible intervals</term><term>Current drinking</term><term>Depressive</term><term>Depressive symptoms</term><term>Desantis</term><term>Disord</term><term>Disorder</term><term>Drinking behavior</term><term>Drinking days</term><term>Drinking outcomes</term><term>Drinking percentage</term><term>Drinking scale</term><term>Drinking state</term><term>Drinks percentage</term><term>Excessive alcohol</term><term>Exclusion criteria</term><term>Fleck</term><term>Forest laboratories</term><term>Future alcohol</term><term>Heavy drinking days</term><term>Heavy drinking state</term><term>Imminent risk</term><term>Latent states</term><term>Madrs</term><term>Manic symptoms</term><term>Markov</term><term>Markov model</term><term>Markov modeling</term><term>Markov models</term><term>Mcmc sampler</term><term>Measurement error</term><term>Medical university</term><term>Montgomery asberg depression rating scale</term><term>Mood outcomes</term><term>Mood symptoms</term><term>Neuropsychiatric interview</term><term>Obsessive</term><term>Ocds</term><term>Odds ratios</term><term>Other studies</term><term>Parameter estimates</term><term>Participant</term><term>Placebo</term><term>Present study</term><term>Prospective association</term><term>Proximal</term><term>Proximal impact</term><term>Psychiatry</term><term>Randomized</term><term>Salloum</term><term>Spearman correlations</term><term>Strakowski</term><term>Study design</term><term>Study psychiatrist</term><term>Study week</term><term>Subsequent alcohol</term><term>Substance abuse</term><term>Summary measures</term><term>Symptom</term><term>Systematic treatment enhancement program</term><term>Treatment group</term><term>Unobserved drinking state</term><term>Weekly visit</term><term>Weiss</term><term>Ymrs</term><term>Ymrs scores</term><term>Young mania rating scale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Bipolar disorders and alcohol use disorders commonly co‐occur, yet little is known about the proximal impact of bipolar symptoms on alcohol use in patients with this comorbidity. The present study examined the impact of depressive symptoms and alcohol craving on proximal alcohol use in patients with co‐occurring bipolar disorder and alcohol dependence. Methods: Data were collected during an 8‐week randomized controlled trial of acamprosate for individuals with co‐occurring bipolar disorder and alcohol dependence (n = 30). Depressive symptoms and alcohol craving were assessed biweekly using the Montgomery Asberg Depression Rating Scale (MADRS) and the Obsessive Compulsive Drinking Scale (OCDS), respectively. Daily alcohol use data were available via administration of the Time‐line Follow‐back interview at baseline and at subsequent weekly study visits. Correlational analyses and hidden Markov modeling were used to examine the prospective relationships between depressive symptoms, alcohol craving, and alcohol use. Results: Depressive symptoms and alcohol craving were significantly correlated with proximal (i.e., 1 week later) alcohol use across a variety of alcohol consumption summary measures. In hidden Markov models, depressive symptoms (OR = 1.3, 95% credible interval = [1.1, 1.5]) and alcohol craving (OR = 1.6, 95% credible interval = [1.4, 1.9]) significantly predicted transitioning from a light to a heavy drinking state, or remaining in a heavy drinking state. Conclusions: The results from the present study suggest that depressive symptoms and alcohol craving increase proximal risk for alcohol use in individuals with co‐occurring bipolar and alcohol use disorders.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Sud</li></region></list><tree><country name="États-Unis"><region name="Caroline du Sud"><name sortKey="Prisciandaro, James J" sort="Prisciandaro, James J" uniqKey="Prisciandaro J" first="James J." last="Prisciandaro">James J. Prisciandaro</name></region><name sortKey="Brady, Kathleen T" sort="Brady, Kathleen T" uniqKey="Brady K" first="Kathleen T." last="Brady">Kathleen T. Brady</name><name sortKey="Brown, Delisa G" sort="Brown, Delisa G" uniqKey="Brown D" first="Delisa G." last="Brown">Delisa G. Brown</name><name sortKey="Chiuzan, Cody" sort="Chiuzan, Cody" uniqKey="Chiuzan C" first="Cody" last="Chiuzan">Cody Chiuzan</name><name sortKey="Desantis, Stacia M" sort="Desantis, Stacia M" uniqKey="Desantis S" first="Stacia M." last="Desantis">Stacia M. Desantis</name><name sortKey="Tolliver, Bryan K" sort="Tolliver, Bryan K" uniqKey="Tolliver B" first="Bryan K." last="Tolliver">Bryan K. Tolliver</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001409 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001409 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F1060A25EBE4BDF27B7C28182B5A3697DC603BFB
|texte= Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co‐Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8‐Week Randomized Controlled Trial of Acamprosate
}}
| This area was generated with Dilib version V0.6.33. |  |